IM Cannabis announces $1.6 million private placement to repay loan
Medical marijuana company IM Cannabis Corp. is planning a non-brokered private placement offering of up to $1.6 million…
News October 10Medical marijuana company IM Cannabis Corp. is planning a non-brokered private placement offering of up to $1.6 million…
News October 10Medical marijuana producer Bedrocan International is returning to the Canadian market through the purchase of a facility in…
News October 10The number of applications and licenses granted for cannabis cultivation social clubs in Germany continued to grow throughout…
News October 3Germany’s long-anticipated “Pillar 2,” which would launch adult-use marijuana sales as part of a limited-duration pilot project, is…
News September 19A British American Tobacco subsidiary acquired roughly 4.4 million Organigram common shares and 8.5 million Class A preferred…
News September 3David Klein, who joined Canopy Growth Corp. as CEO in 2020, will retire at the end of company’s…
News August 16Germany’s recreational cannabis market has limited opportunity, but Bloomwell Group's Niklas Kouparanis is bullish on the medical market.
News July 30IM Cannabis Corp., a medical marijuana company operating in Israel and Germany, said it has regained compliance with…
News July 30Aphria RX, the Neumünster, Germany-based subsidiary of Tilray Brands, said Monday it received a medical marijuana cultivation license…
News July 22A growing number of European cannabis startups are considering initial public offerings in the United States, where they…
News July 18